Aortic Aneurysm Stent Grafts Market to Grow at a CAGR of 5.71% Through 2030, Driven by Rising Aneurysm Prevalence and Advancements in Endovascular Repair Technologies

Posted on
by

The Aortic Aneurysm Stent Grafts Market is witnessing significant growth owing to the increasing burden of vascular diseases, rising geriatric population, growing preference for minimally invasive aneurysm repair procedures, and continuous technological advancements in stent graft systems. Leading companies including Medtronic, Terumo, Cook Medical, Endologix, W. L. Gore & Associates, and Endospan are actively advancing innovative solutions to improve patient outcomes and expand treatment accessibility.

DelveInsight’s latest market intelligence report, “Aortic Aneurysm Stent Grafts Market Insight, Competitive Landscape and Market Forecast, 2030,” highlights the evolving landscape of endovascular aneurysm repair technologies and forecasts sustained market growth through 2030. The global Aortic Aneurysm Stent Grafts Market is projected to expand at a CAGR of 5.71% during the forecast period from 2024 to 2030.

The market growth is primarily fueled by the increasing prevalence of abdominal and thoracic aortic aneurysms, growing incidence of diabetes and cardiovascular disorders, favorable reimbursement policies, and rising adoption of minimally invasive procedures such as Endovascular Aneurysm Repair (EVAR) and Thoracic Endovascular Aortic Repair (TEVAR).

Discover comprehensive Aortic Aneurysm Stent Grafts market forecasts, competitive intelligence, and emerging technology trends

Increasing Burden of Vascular Aortic Aneurysm Stent Grafts Driving Market Expansion

Aortic aneurysms remain a major cardiovascular health concern globally, particularly among aging populations and patients with diabetes, hypertension, obesity, and atherosclerosis. According to the International Diabetes Federation, approximately 537 million adults were living with diabetes in 2021, a figure expected to rise substantially over the next two decades. The increasing prevalence of diabetes-associated vascular complications is contributing to the growing demand for advanced aneurysm management solutions, including stent graft systems.

The shift toward minimally invasive interventions has significantly transformed aneurysm treatment approaches. Compared with conventional open surgery, EVAR and TEVAR procedures offer reduced operative trauma, shorter hospital stays, and improved recovery outcomes, further strengthening adoption rates worldwide.

Want to understand how rising diabetes prevalence, aging demographics, and cardiovascular disease trends are influencing market demand? Access the full market assessment today.https://www.delveinsight.com/report-store/aortic-aneurysm-stent-grafts-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=mpr

Aortic Aneurysm Stent Grafts Recent Development

Recent product innovations include:

  • In August 2024, Terumo India launched the TREO® Stent-Graft System for the treatment of infrarenal abdominal aortic aneurysms, featuring both suprarenal and infrarenal active fixation.

  • In June 2024, Medtronic introduced the Steerant™ Aortic Guidewire to facilitate catheter placement and exchange during aortic interventions.

  • In May 2025, Endospan presented positive 30-day results from the TRIOMPHE IDE clinical study evaluating the NEXUS® Aortic Arch Stent-Graft System.

  • Cook Medical received FDA approval to initiate an IDE study for its Zenith Fenestrated+ Endovascular Graft (ZFEN+) designed for complex aneurysm treatment.

These advancements are expected to accelerate procedural adoption and improve long-term clinical outcomes.

Explore detailed profiles of emerging stent graft technologies, ongoing clinical trials, regulatory milestones, and innovation strategies adopted by leading manufacturers.https://www.delveinsight.com/report-store/aortic-aneurysm-stent-grafts-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=mpr

Abdominal Aortic Stent Grafts Segment Expected to Lead Market Revenue

Based on product segmentation, the abdominal aortic stent graft category is expected to account for a substantial share of the market during the forecast period.

Abdominal aortic stent grafts have become the preferred treatment option for abdominal aortic aneurysms due to their minimally invasive nature and strong clinical efficacy. The devices incorporate advanced anchoring mechanisms, self-expanding technologies, and customized fenestration designs that enhance procedural success while minimizing complications.

Increasing product customization and ongoing innovation aimed at addressing diverse patient anatomies are further strengthening growth opportunities within this segment.

North America Maintains Aortic Aneurysm Stent Grafts Market Leadership

North America is anticipated to remain the largest regional market for aortic aneurysm stent grafts throughout the forecast period.

The region’s dominance is supported by:

  • High prevalence of diabetes and cardiovascular diseases

  • Strong presence of leading device manufacturers

  • Advanced healthcare infrastructure

  • Favorable reimbursement frameworks

  • Robust regulatory support for innovative technologies

Recent milestones supporting regional growth include Endologix’s ALTO® Abdominal Stent Graft approval in Canada and FDA approval of Terumo Aortic’s RelayPro Thoracic Stent-Graft System in the United States.

Meanwhile, the Asia-Pacific region is expected to witness the fastest growth owing to expanding healthcare infrastructure, increasing awareness, rising healthcare expenditures, and growing access to advanced endovascular therapies.

Gain actionable insights into regional growth opportunities, reimbursement scenarios, market drivers, and competitive positioning across North America, Europe, Asia-Pacific, and Rest of the World.https://www.delveinsight.com/report-store/aortic-aneurysm-stent-grafts-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=mpr

Key Companies Operating in the Aortic Aneurysm Stent Grafts Market

Major companies shaping the competitive landscape include:

  • Medtronic

  • Terumo Corporation

  • MicroPort Scientific Corporation

  • Cook Medical

  • Cordis

  • W. L. Gore & Associates, Inc.

  • Endologix LLC

  • SB-KAWASUMI LABORATORIES, INC.

  • Endospan

  • Lombard Medical

These organizations continue to focus on strategic collaborations, regulatory approvals, clinical studies, and product innovation initiatives to strengthen their market positions and address evolving clinical needs.

Aortic Aneurysm Stent Grafts Market Outlook

As healthcare systems increasingly embrace minimally invasive cardiovascular interventions and the global burden of aneurysmal disease continues to rise, the Aortic Aneurysm Stent Grafts Market is expected to witness robust expansion through 2030. Continued technological advancements, favorable reimbursement support, and growing physician expertise in endovascular procedures are anticipated to drive sustained market momentum.

Stay ahead of evolving market dynamics with in-depth forecasts, company benchmarking, product pipeline analysis, and strategic business intelligence from DelveInsight.https://www.delveinsight.com/report-store/aortic-aneurysm-stent-grafts-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=mpr

About DelveInsight

DelveInsight is a leading business Healthcare consultancy and market research firm specializing in life sciences. It assists pharmaceutical companies by offering comprehensive end-to-end solutions to improve their business performance. DelveInsight’s expert healthcare consulting services provide market intelligence, competitive benchmarking, epidemiology analysis, pipeline assessment, and strategic insights that help organizations make informed business decisions.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Mehul Malhotra
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/